Efficient. Safe. Cost effective.
Cilian AG is an innovative biotechnology company that uses the unique capabilities of ciliates for the industrial production of therapeutic proteins.
Cilian is able to render the production process more efficient, cost-effective and safer than conventional production methods for biopharmaceuticals. This unique technology is offered to the pharmaceutical and biotech industry as a patented CIBEX system.
Technology
The CIBEX system is an innovative expression platform for the highly productive fabrication of protein-based biopharmaceuticals.
CIBEX is based on ciliates, an apathogenic eukaryotic protozoan organism that ideally combines the advantages of various conventional expression platforms.
Research and Development
In addition to striving to optimise the CIBEX platform for the general production of various biopharmaceuticals, therapeutic proteins are also being developed in various other areas:
- Vaccines
- Enzymes
- Monoclonal antibodies
CURRENT INFORMATION
Press material
26. July 2023
Press material
21. February 2023
